Arnaud Lagarde
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Genetic factors in colorectal cancer 7
- Genetics 10
- Genetic and rare skin diseases. 4
- Genomics and Rare Diseases 4
- Genomic variations and chromosomal abnormalities 2
- Co-authors
- Sylviane Olschwang (15 shared papers)Daniel Birnbaum (9 shared papers)José Adélaı̈de (7 shared papers)Max Chaffanet (3 shared papers)Julien Mozziconacci (2 shared papers)Luc Xerri (2 shared papers)Norbert Vey (1 shared paper)Nathalie Cervera (1 shared paper)
In The Last Decade
Arnaud Lagarde
31 papers receiving 2.3k citations
Arnaud Lagarde's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 808
- Hematology 374
- Cancer Research 267
- Pathology and Forensic Medicine 325
- Molecular Biology 764
Countries citing papers authored by Arnaud Lagarde
This map shows the geographic impact of Arnaud Lagarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Lagarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Lagarde more than expected).
Fields of papers citing papers by Arnaud Lagarde
This network shows the impact of papers produced by Arnaud Lagarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Lagarde. The network helps show where Arnaud Lagarde may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnaud Lagarde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value Hit paper breakdown → | 2013 | 1148 |
| 2 | Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia Hit paper breakdown → | 2009 | 486 |
| 3 | 2011 | 108 | |
| 4 | 2008 | 63 | |
| 5 | 2012 | 62 | |
| 6 | 2007 | 49 | |
| 7 | 2017 | 46 | |
| 8 | 2012 | 38 | |
| 9 | 2010 | 37 | |
| 10 | 2016 | 27 | |
| 11 | 2014 | 26 | |
| 12 | 2007 | 24 | |
| 13 | 2015 | 23 | |
| 14 | 2019 | 20 | |
| 15 | 2020 | 19 | |
| 16 | 2012 | 18 | |
| 17 | 2019 | 18 | |
| 18 | 2022 | 16 | |
| 19 | 2019 | 12 | |
| 20 | 2019 | 12 |
About Arnaud Lagarde
Arnaud Lagarde is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Epidemiology and Molecular Biology, having authored 32 papers that have together received 2.3k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (7 papers), Neuroendocrine Tumor Research Advances (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Genetic and rare skin diseases. (4 papers), Genomics and Rare Diseases (4 papers), Muscle Physiology and Disorders (3 papers), Genomic variations and chromosomal abnormalities (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (808 citations), Hematology (374 citations), Cancer Research (267 citations), Pathology and Forensic Medicine (325 citations) and Molecular Biology (764 citations). Arnaud Lagarde has collaborated with scholars based in France, Tunisia and Belgium. Frequent co-authors include Sylviane Olschwang, Daniel Birnbaum, José Adélaı̈de, Max Chaffanet, Julien Mozziconacci, Luc Xerri, Norbert Vey, Nathalie Cervera, Véronique Gelsi‐Boyer and Thomas Prébet. Their work appears in journals such as European Journal of Endocrinology, Frontiers in Genetics, BMC Cancer, Digestive and Liver Disease and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.